Risk of rhabdomyolysis from 5-reductase inhibitors

摘要

PurposeA recent regulatory warning and case reports have described the development of muscle complications with the use of 5- reductase inhibitors (5ARIs). We wished to determine if there was a link between rhabdomyolysis and 5ARI usage.